Targeted Therapy in Head and Neck Cancer

被引：3
|
作者：
Ward, Brent B. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA | 2013年 / 25卷 / 01期
关键词：
Cancer; Nanotechnology; Chemotherapy; Radiation; Targeted therapy; SQUAMOUS-CELL CARCINOMA; TRANSORAL ROBOTIC SURGERY; LYMPH-NODE BIOPSY; SURGICAL MARGINS; PLUS CETUXIMAB; SIGNALING NETWORK; ANIMAL-MODEL; ORAL-CANCER; DISSECTION; CHEMOTHERAPY;
D O I：
10.1016/j.coms.2012.11.006
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
The desire to target therapies to specific cancers while leaving the host unharmed remains an ongoing quest for scientists, surgeons, radiation oncologists, and medical oncologists. In recent years, great scientific progress has been made in targeted therapies. Although many modalities remain in preclinical validation, some advances affect patient care today. This article summarizes the concepts of targeting and explores current examples of successful targeting and emerging targeting technologies in head and neck oncology.
引用
收藏
页码：83 / +
页数：12
相关论文
共 50 条
  • [31] FGFR-targeted therapy in head and neck carcinomas
    Dietrich, Dimo
    HNO, 2021, 69 (03) : 172 - 184
  • [32] Current aspects of targeted therapy in head and neck tumors
    Dietz, Andreas
    Boehm, Andreas
    Mozet, Christian
    Wichmann, Gunnar
    Giannis, Athanassios
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2008, 265 (Suppl 1) : S3 - S12
  • [33] Current aspects of targeted therapy in head and neck tumors
    Andreas Dietz
    Andreas Boehm
    Christian Mozet
    Gunnar Wichmann
    Athanassios Giannis
    European Archives of Oto-Rhino-Laryngology, 2008, 265 : 3 - 12
  • [34] Postoperative treatment for head and neck cancer: the emerging role of EGFR-targeted therapy
    Argiris, Athanassios
    Rapidis, Alexander D.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (01) : 17 - 19
  • [35] EGFR targeted iron-oxide nanoparticles for photodynamic therapy in head and neck cancer
    Wang, Dongsheng
    Qin, Xulei
    Qian, Guoqing
    Halig, Luma
    Fei, Baowei
    Chen, Zhengjia
    Chen, Zhuo Georgia
    Saba, Nabil F.
    Shin, Dong M.
    Xu, Hong
    Wang, Andrew Y.
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
    Sacco, Assuntina G.
    Worden, Francis P.
    ONCOTARGETS AND THERAPY, 2016, 9 : 1927 - 1943
  • [37] Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit
    Mascarella, M.
    Olonisakin, T.
    Rumde, P.
    Vendra, V.
    Nance, M.
    Kim, S.
    Kubik, M.
    Sridharan, S.
    Ferris, R.
    Moon, F.
    Clayburgh, D.
    Ohr, J.
    Joyce, S.
    Sen, M.
    Herman, J.
    Grandis, J.
    Zandberg, D.
    Duvvuri, U.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S128 - S128
  • [38] The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model
    Marcu, Loredana G.
    Marcu, David
    CELL PROLIFERATION, 2017, 50 (06)
  • [39] Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit
    Mascarella, Marco Antonio
    Olonisakin, Tolani
    Rumde, Purva
    Vendra, Varun
    Nance, Melonie
    Kim, Seungwon
    Kubik, Mark
    Sridharan, Shaum
    Ferris, Robert
    Fenton, Moon
    Clayburgh, Daniel
    Ohr, James
    Sen, Malabika
    Joyce, Sonali
    Herman, James
    Grandis, Jennifer
    Zandberg, Dan
    Duvvuri, Umamaheswar
    CANCER RESEARCH, 2023, 83 (07)
  • [40] Targeted therapy in head and neck cancer - State of the art 2007 and review of clinical applications
    Langer, Corey J.
    CANCER, 2008, 112 (12) : 2635 - 2645
12345